Log in to save to my catalogue

Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiform...

Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiform...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A641057642

Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme

About this item

Full title

Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme

Publisher

American Society for Clinical Investigation

Journal title

Journal of Clinical Investigation, 2020, Vol.130 (11), p.6041

Language

English

Formats

Publication information

Publisher

American Society for Clinical Investigation

More information

Scope and Contents

Contents

TRIAL REGISTRATION. anzctr.org.au: ACTRN12615000656538.

Alternative Titles

Full title

Autologous CMV-specific T cells are a safe adjuvant immunotherapy for primary glioblastoma multiforme

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A641057642

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A641057642

Other Identifiers

ISSN

0021-9738

DOI

10.1172/JCI138649

How to access this item